Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis

Kennedy, LindseyAlpini, Gianfranco2023-06-152023-06-152022Kennedy L, Alpini G. Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis. Cell Mol Gastroenterol Hepatol. 2022;13(4):1259-1260. doi:10.1016/j.jcmgh.2022.01.009https://hdl.handle.net/1805/33786en-USAttribution-NonCommercial-NoDerivatives 4.0 InternationalSclerosing cholangitisCannabinoid receptorsInflammationFibrogenesisCannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing CholangitisArticle